David Hoffmann
Director/Board Member bij MOLECULAR TEMPLATES, INC.
Vermogen: 36 800 $ op 29-02-2024
Profiel
Currently, David R.
Hoffmann occupies the position of Chief Executive Officer at Hoffmann Associates.
Mr. Hoffmann is also on the board of Molecular Templates, Inc. and Molecular Templates OpCo, Inc.
In his past career Mr. Hoffmann held the position of Director at DURECT Corp.
and Treasurer & Vice President for ALZA Corp.
Mr. Hoffmann received an undergraduate degree from The University of Colorado.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
DURECT CORPORATION
0.12% | 25-04-2023 | 36 800 ( 0.12% ) | 36 800 $ | 29-02-2024 |
27-10-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van David Hoffmann
Bedrijven | Functie | Begin |
---|---|---|
MOLECULAR TEMPLATES, INC. | Director/Board Member | 01-08-2017 |
Hoffmann Associates
Hoffmann Associates Engineering & ConstructionIndustrial Services Hoffmann Associates provides architectural services for homes, remodels, additions, and kitchen renovations. The company was founded in 1993 and is headquartered in Boulder, CO. | Chief Executive Officer | - |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Director/Board Member | - |
Eerdere bekende functies van David Hoffmann
Bedrijven | Functie | Einde |
---|---|---|
DURECT CORPORATION | Chairman | 17-03-2023 |
ALZA CORPORATION | Director of Finance/CFO | 01-01-1992 |
Therapeutic Discovery Corp.
Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Director/Board Member | - |
Alza Development Corp. | Director/Board Member | - |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Director/Board Member | - |
Opleiding van David Hoffmann
The University of Colorado | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DURECT CORPORATION | Health Technology |
MOLECULAR TEMPLATES, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Therapeutic Discovery Corp.
Therapeutic Discovery Corp. Pharmaceuticals: MajorHealth Technology Therapeutic Discovery Corp. developed and commercialized new human pharmaceutical products combining proprietary drug delivery technology. The company was headquartered in Fremont, CA. | Health Technology |
Crescendo Pharmaceuticals Corp.
Crescendo Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Crescendo Pharmaceuticals Corp. develops pharmaceutical products. The company is headquartered in Mountain View, CA. | Health Technology |
Alza Development Corp. | |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
Hoffmann Associates
Hoffmann Associates Engineering & ConstructionIndustrial Services Hoffmann Associates provides architectural services for homes, remodels, additions, and kitchen renovations. The company was founded in 1993 and is headquartered in Boulder, CO. | Industrial Services |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |